Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

Why CSL (ASX:CSL) Is Resetting Its Strategy After a US$2.6 Billion FY2026 Loss

Despite the statutory loss, CSL reported continued underlying profitability, supported by its plasma therapies business and ongoing cost management initiatives. The company said FY2026 represented a period of restructuring and business reset as it focused on improving operational performance and positioning the group for …

Sonal Goyal | 17 September 2026

Echo IQ (ASX:EIQ) Outlines Path Forward After FDA Submission Update

Echo IQ Limited (ASX:EIQ) has provided an update on the regulatory status of its EchoSolv HF submission after receiving a Not Substantially Equivalent, or NSE, determination from the United States Food and Drug Administration. The Sydney-based company said it continues to see a clear …

Sonal Goyal | 17 September 2026

Resonance Health (ASX:RHT): Inside the FY26 Results and Outlook

Resonance Health Ltd (ASX:RHT) has reported an improved set of financial results for the year ended 30 June 2026, highlighting a broader shift in the company's underlying performance across its diagnostic technology and clinical trial services businesses. The results mark a return to full-year …

Sonal Goyal | 17 September 2026

Hydrix (ASX:HYD) Secures Multi-Year Cardiac Monitoring Contract With Singapore's NHCS

The estimated contract value is approximately A$0.625 million over three years, subject to the actual patient volumes monitored under the platform during that period. On this basis, the company has estimated annual recurring revenue of approximately A$0.21 million over the agreed three-year term, though …

Sonal Goyal | 17 September 2026

Nanosonics Ltd (ASX:NAN) in Focus: Infection Prevention Technology and FY26 Financial Performance

Nanosonics Ltd (ASX:NAN) is an Australian healthcare technology company focused on infection prevention solutions for medical environments. The company’s core technology supports automated disinfection of ultrasound probes, addressing the need for consistent infection control practices across healthcare facilities.

Sonal Goyal | 17 September 2026

Mesoblast Ltd (ASX:MSB) in Focus: Ryoncil Commercialisation, Cell Therapy Pipeline and FY26 Progress

Mesoblast Ltd (ASX:MSB) is a biotechnology company focused on developing cell therapy products for inflammatory diseases, immune disorders and other medical conditions. The company’s FY26 results highlighted commercial progress from Ryoncil, continuedInvestmentin clinical programs and ongoing development of its broader cell therapy pipeline. (Mesoblast)

Sonal Goyal | 17 September 2026

Neuren Pharmaceuticals Ltd (ASX:NEU) in Focus: Royalty Growth, DAYBUE Commercialisation and Dividend Program

Neuren Pharmaceuticals Ltd (ASX:NEU) is an Australian biotechnology company focused on developing and commercialising treatments for neurological disorders. The company’s recent focus has shifted towards commercial revenue generation following growth in royalty income from DAYBUE and the introduction of its first dividend program.

Sonal Goyal | 17 September 2026

PYC Therapeutics Ltd (ASX:PYC) in Focus: Biotechnology Platform and Market Update

PYC Therapeutics Ltd (ASX:PYC) is an Australian biotechnology company focused on developing precision medicines using RNA-based technologies. The company operates within the healthcare sector, where research progress, clinical development and regulatory milestones are important factors influencing biotechnology businesses.

Sonal Goyal | 17 September 2026

4DMedical Ltd (ASX:4DX) in Focus: Medical Imaging Technology and FY26 Commercial Progress

4DMedical Ltd (ASX:4DX) is an Australian medical technology company focused on developing advanced imaging solutions for respiratory health. The company’s technology platform is designed to provide detailed insights into lung function through non-invasive imaging methods.

Sonal Goyal | 17 September 2026

Ryman Healthcare Ltd (ASX:RYM) in Focus: Retirement Living Operations and FY27 Trading Update

Ryman Healthcare Ltd (ASX:RYM) is a healthcare and retirement living provider operating integrated retirement villages, aged care facilities and related services. The company’sBusinessmodel combines independent living, assisted care and healthcare services for older residents across New Zealand and Australia.

Sonal Goyal | 17 September 2026
Support

Hi! How can we help you today?

Loading…